Researchers are investigating whether being right handed is due to genetics or other factors.
|
By MedImaging International staff writers Posted on 03 Nov 2008 |
A multidisciplinary team of researchers is evaluating whether tissue optical spectroscopy can be utilized for early cancer detection in the pancreas during minimally invasive endoscopic diagnostic procedures.
Their objective is to help physicians distinguish between cancerous tissue transformations and benign changes in tissues due to different diseases, such as pancreatitis. Doing this can speed an accurate diagnosis and treatment to generate better patient outcomes. Pancreatic cancer is the fourth leading cause of cancer death in the United States alone; 95% of all patients diagnosed with the disease will die from it, more than half within six months of diagnosis.
"Until better treatment approaches can be developed, the only opportunity to change disease-associated mortality in pancreatic cancer patients is earlier diagnosis,” explained Mary-Ann Mycek, associate professor and associate chair of the University of Michigan (Ann Arbor, USA), department of biomedical engineering. "Current diagnostic methods have not been able to provide accurate diagnoses in early stages of the disease.”
The Michigan team's goal is to develop an optical technique to detect pancreatic cancer in patients at early stages--a development that could greatly improve the chances of patient survival by meeting the critical, unmet need of accurately differentiating malignant masses from benign pancreatitis. Such improved diagnostic accuracy could also appropriately triage patients, thereby preventing those without cancer from having unnecessary surgery.
To accomplish this, investigators used a multimodal optical spectroscopy approach based on observing reflectance and fluorescence properties of pancreatic tissue samples. Spectral analysis showed significant differences between normal, pancreatitis (inflammation), and cancerous tissues, thus suggesting noninvasive diagnostic possibilities for distinguishing among disease states.
The theory behind optically based diagnostics is this: in the body, the presence of disease alters tissue properties, such as local biochemistry and structure. Optically based disease diagnostic techniques can probe microscopic tissue alterations for signatures of disease, thereby leading to noninvasive diagnostics in living patients. Once detected optically, such diseased tissue may be treated. Because optical techniques do not require the removal of tissue, they could represent an advance in patient care over the invasive practice of tissue biopsy.
The study's findings were presented at Frontiers in Optics 2008 (FiO), the 92nd annual meeting of the Optical Society (OSA), which was held October 19-23, 2008, in Rochester, NY, USA.
Related Links:
University of Michigan
Their objective is to help physicians distinguish between cancerous tissue transformations and benign changes in tissues due to different diseases, such as pancreatitis. Doing this can speed an accurate diagnosis and treatment to generate better patient outcomes. Pancreatic cancer is the fourth leading cause of cancer death in the United States alone; 95% of all patients diagnosed with the disease will die from it, more than half within six months of diagnosis.
"Until better treatment approaches can be developed, the only opportunity to change disease-associated mortality in pancreatic cancer patients is earlier diagnosis,” explained Mary-Ann Mycek, associate professor and associate chair of the University of Michigan (Ann Arbor, USA), department of biomedical engineering. "Current diagnostic methods have not been able to provide accurate diagnoses in early stages of the disease.”
The Michigan team's goal is to develop an optical technique to detect pancreatic cancer in patients at early stages--a development that could greatly improve the chances of patient survival by meeting the critical, unmet need of accurately differentiating malignant masses from benign pancreatitis. Such improved diagnostic accuracy could also appropriately triage patients, thereby preventing those without cancer from having unnecessary surgery.
To accomplish this, investigators used a multimodal optical spectroscopy approach based on observing reflectance and fluorescence properties of pancreatic tissue samples. Spectral analysis showed significant differences between normal, pancreatitis (inflammation), and cancerous tissues, thus suggesting noninvasive diagnostic possibilities for distinguishing among disease states.
The theory behind optically based diagnostics is this: in the body, the presence of disease alters tissue properties, such as local biochemistry and structure. Optically based disease diagnostic techniques can probe microscopic tissue alterations for signatures of disease, thereby leading to noninvasive diagnostics in living patients. Once detected optically, such diseased tissue may be treated. Because optical techniques do not require the removal of tissue, they could represent an advance in patient care over the invasive practice of tissue biopsy.
The study's findings were presented at Frontiers in Optics 2008 (FiO), the 92nd annual meeting of the Optical Society (OSA), which was held October 19-23, 2008, in Rochester, NY, USA.
Related Links:
University of Michigan
Latest General/Advanced Imaging News
- New SPECT/CT Method Differentiates Inflammation from Fibrosis in Interstitial Lung Disease
- Whole-Body PET/CT Tracks Metabolic Changes After Bariatric Surgery
- PET Tracer Localizes Overactive Adrenal Glands in Primary Aldosteronism
- Multimodal AI Tool Combines CT and Health Records to Predict Heart Risk
- AI Tool Automates Radiotherapy Planning for Cervical and Prostate Cancer
- New Proton Therapy Platform Integrates into Existing Radiotherapy Departments
- 3D-Printed Intraoral Device Enhances Head and Neck Radiotherapy Accuracy
- Molecular Imaging Agent Shows Promise for Endometriosis Detection and Monitoring
- Automated AI Tool Detects Early Pancreatic Cancer on Routine CT
- Routine Cardiac CT Enhanced to Predict Heart Failure Risk
- New Breast Imaging Viewer Unifies Modalities and Enhances Clinical Workflow
- Radiomics Analysis of CT Scans Enhances Evaluation of Sarcoidosis
- Hybrid AI System Improves Early Lung Cancer Detection on CT
- AI Tool Predicts Side Effects from Lung Cancer Treatment
- AI Tool Offers Prognosis for Patients with Head and Neck Cancer
- New 3D Imaging System Addresses MRI, CT and Ultrasound Limitations
Channels
Radiography
view channel
Rapid X-Ray Test Quantifies Pulmonary Regurgitation After Tetralogy of Fallot Repair
Tetralogy of Fallot is the most common cyanotic congenital heart defect and can leave patients with pulmonary valve regurgitation, a backward flow of blood into the right ventricle after repair.... Read more
AI Tool Flags Osteoporosis Risk from Routine Chest X-Rays
Osteoporosis is a progressive loss of bone density that is often silent until a fracture occurs. Current screening frameworks concentrate on older women and select high-risk groups. Many men, younger adults,... Read moreMRI
view channel
AI Approach Could Shorten Advanced Brain MRI Scans by Up to 90%
Long acquisition times for advanced brain magnetic resonance imaging (MRI) can limit access, extend waiting lists, and disrupt clinical workflows. Reducing data requirements without sacrificing image fidelity... Read more
Cardiac MRI Measure Improves Risk Prediction in Tricuspid Regurgitation
Tricuspid regurgitation, in which blood flows back from the right ventricle into the right atrium, can lead to progressive right-sided heart failure. Clinicians need reliable ways to gauge severity and... Read moreUltrasound
view channelAI Robotic Ultrasound System Automates Echocardiography and Improves Consistency
Echocardiography, an ultrasound examination of the heart, is central to diagnosing and managing cardiovascular disease. Many services struggle with limited availability of skilled sonographers, variable... Read more
Whole Cross-Section Ultrasound System Enables Operator-Independent Imaging
Conventional ultrasound is central to bedside imaging but is limited by a narrow field of view and operator variability. Comprehensive cross-sectional assessment typically requires computed tomography... Read moreNuclear Medicine
view channel
Targeted PET Platform Guides Osteosarcoma Resection and Margin Verification
Osteosarcoma, an aggressive primary bone cancer that mainly affects children and adolescents, demands wide excision to prevent local recurrence. Surgeons must achieve negative margins while preserving... Read more
Portable PET System Enables Real-Time Bedside Guidance for Biopsies and Ablations
Interventional radiology procedures typically rely on ultrasound, X-ray fluoroscopy, or computed tomography for image guidance. These modalities visualize anatomy but offer limited molecular information,... Read moreImaging IT
view channel
Interactive AI Tool Supports Explainable Lung Nodule Assessment
Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026
Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
GE HealthCare Highlights AI-Supported Radiation Therapy Tools at ESTRO 2026
At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare is highlighting Intelligent Radiation Therapy (iRT), MIM Software innovations, and BK Medical surgical... Read more







